Skip to main content
. 2020 Aug 21;16(3):318–336. doi: 10.1016/j.ajps.2020.07.003

Fig. 4.

Fig. 4

GSH-triggered magnetic complex of sorafenib and nanophotosensitizer (CSO-SS-Cy7-Hex/SPION/Srfn) for the comprehensive ferroptosis therapy. (A) Schematic illustration for the preparation of CSO-SS-Cy7-Hex/SPION/Srfn.(B) Sorafenib release profiles at different light or GSH conditions. (C) Iron release profiles at different light or GSH conditions. (D) Tumor sizes with time after different treatments. Adapted with permission from [60]. Copyright 2019, Ivyspring International Publisher.